tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Matt Dellatorre, 3 are a HOLD (42.86%), 4 are a BUY (57.14%).
Analyst Matt Dellatorre, currently employed at GOLDMAN SACHS, carries an average stock price target met ratio of 87.5% that have a potential upside of 18.34% achieved within 59 days.
Matt Dellatorre’s has documented 14 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TEVA, Teva Pharma Industries Ltd ADR at 09-Feb-2026.
Analyst best performing recommendations are on VTRS (VIATRIS).
The best stock recommendation documented was for TEVA (TEVA PHARMA INDUSTRIES LTD ADR) at 12/8/2025. The price target of $31 was fulfilled within 14 days with a profit of $2.67 (9.42%) receiving and performance score of 6.73.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 13-May-2024
$44
$8.99 (25.68%)
$42
7 days ago
(28-Jul-2026)
13/23 (56.52%)
$12.33 (38.93%)
246
Buy Since 11-Mar-2024
$40
$4.99 (14.25%)
$38
2 months 29 days ago
(06-May-2026)
5/8 (62.5%)
$3.66 (10.07%)
117
Buy Since 28-May-2025
$45
$9.99 (28.53%)
$42
3 months 5 days ago
(30-Apr-2026)
1/4 (25%)
$9.93 (28.31%)
168
Buy Since 01-Feb-2024
$42
$6.99 (19.97%)
$37
3 months 5 days ago
(30-Apr-2026)
10/12 (83.33%)
$6.93 (19.76%)
179
Buy Since 11-May-2023
$42
$6.99 (19.97%)
$22
3 months 26 days ago
(09-Apr-2026)
16/23 (69.57%)
$11.04 (35.66%)
157
Which stock is Matt Dellatorre is most bullish on?
What Year was the first public recommendation made by Matt Dellatorre?
